NJ A5383

Requires Medicaid to cover ovulation enhancing drugs and related medical services for beneficiaries ages 21-44 experiencing infertility, contingent on federal financial participation

Limits covered medical services to office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing related to prescribing and monitoring ovulation enhancing drugs

Caps coverage at three cycles of treatment per beneficiary's lifetime

Defines infertility as failure to conceive after 12 months of unprotected intercourse for ages 21-34, or after 6 months for ages 35-44, with protections ensuring coverage cannot be denied based on relationship status or sexual orientation

Directs the Commissioner of Human Services to apply for necessary federal waivers and adopt implementing regulations, with the act taking effect on the first day of the fourth month following enactment